Charles Schwab Investment Management Inc Heron Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $557 Billion
  • Q2 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,186,120 shares of HRTX stock, worth $1.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,186,120
Previous 1,089,449 8.87%
Holding current value
$1.41 Million
Previous $2.4 Million 2.46%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
BUY
$1.72 - $2.42 $166,274 - $233,943
96,671 Added 8.87%
1,186,120 $2.46 Million
Q1 2025

Sep 15, 2025
SELL
$1.47 - $2.55 $142,106 - $246,511
-96,671 Reduced 8.15%
1,089,449 $2.4 Million
Q1 2025

May 09, 2025
SELL
$1.47 - $2.55 $24,040 - $41,702
-16,354 Reduced 1.48%
1,089,449 $2.4 Million
Q4 2024

Feb 06, 2025
BUY
$1.06 - $2.12 $9,983 - $19,966
9,418 Added 0.86%
1,105,803 $1.69 Million
Q3 2024

Nov 12, 2024
SELL
$1.73 - $3.67 $71,641 - $151,978
-41,411 Reduced 3.64%
1,096,385 $2.18 Million
Q2 2024

Aug 12, 2024
BUY
$2.32 - $3.86 $108,246 - $180,099
46,658 Added 4.28%
1,137,796 $3.98 Million
Q1 2024

May 08, 2024
BUY
$1.71 - $3.06 $160,632 - $287,447
93,937 Added 9.42%
1,091,138 $3.02 Million
Q4 2023

Feb 06, 2024
BUY
$0.54 - $1.82 $7,663 - $25,829
14,192 Added 1.44%
997,201 $1.7 Million
Q3 2023

Nov 08, 2023
BUY
$0.97 - $1.8 $232,247 - $430,974
239,430 Added 32.2%
983,009 $1.01 Million
Q2 2023

Aug 09, 2023
BUY
$1.11 - $2.88 $13,822 - $35,864
12,453 Added 1.7%
743,579 $862,000
Q1 2023

May 11, 2023
SELL
$1.51 - $3.25 $101,047 - $217,486
-66,919 Reduced 8.39%
731,126 $1.1 Million
Q4 2022

Feb 13, 2023
BUY
$2.25 - $4.67 $128,337 - $266,372
57,039 Added 7.7%
798,045 $2 Million
Q3 2022

Nov 14, 2022
BUY
$2.66 - $5.37 $26,469 - $53,436
9,951 Added 1.36%
741,006 $3.13 Million
Q2 2022

Aug 15, 2022
BUY
$2.3 - $6.29 $36,222 - $99,061
15,749 Added 2.2%
731,055 $2.04 Million
Q1 2022

May 13, 2022
BUY
$4.63 - $9.94 $88,196 - $189,347
19,049 Added 2.74%
715,306 $4.09 Million
Q4 2021

Feb 11, 2022
SELL
$8.35 - $12.6 $2,246 - $3,389
-269 Reduced 0.04%
696,257 $6.36 Million
Q3 2021

Nov 16, 2021
BUY
$10.13 - $15.0 $598,480 - $886,200
59,080 Added 9.27%
696,526 $7.45 Million
Q2 2021

Aug 16, 2021
BUY
$13.27 - $18.48 $900,170 - $1.25 Million
67,835 Added 11.91%
637,446 $9.89 Million
Q1 2021

May 17, 2021
BUY
$14.49 - $20.72 $229,956 - $328,826
15,870 Added 2.87%
569,611 $9.23 Million
Q4 2020

Feb 16, 2021
BUY
$14.61 - $22.14 $155,698 - $235,945
10,657 Added 1.96%
553,741 $11.7 Million
Q3 2020

Nov 13, 2020
BUY
$13.67 - $17.77 $44,400 - $57,716
3,248 Added 0.6%
543,084 $8.05 Million
Q2 2020

Aug 14, 2020
BUY
$10.89 - $21.47 $450,584 - $888,342
41,376 Added 8.3%
539,836 $7.94 Million
Q1 2020

May 15, 2020
BUY
$10.23 - $24.56 $68,387 - $164,183
6,685 Added 1.36%
498,460 $5.85 Million
Q4 2019

Feb 07, 2020
BUY
$17.42 - $26.61 $1.14 Million - $1.73 Million
65,162 Added 15.27%
491,775 $11.6 Million
Q3 2019

Nov 08, 2019
BUY
$16.36 - $21.39 $145,195 - $189,836
8,875 Added 2.12%
426,613 $7.89 Million
Q2 2019

Aug 09, 2019
BUY
$16.93 - $26.22 $364,316 - $564,228
21,519 Added 5.43%
417,738 $7.77 Million
Q1 2019

May 14, 2019
BUY
$23.15 - $28.34 $340,629 - $416,994
14,714 Added 3.86%
396,219 $9.68 Million
Q4 2018

Feb 14, 2019
BUY
$22.03 - $32.01 $54,193 - $78,744
2,460 Added 0.65%
381,505 $9.9 Million
Q3 2018

Nov 13, 2018
BUY
$30.0 - $40.85 $1.5 Million - $2.05 Million
50,064 Added 15.22%
379,045 $12 Million
Q2 2018

Aug 08, 2018
BUY
$26.4 - $42.0 $1.56 Million - $2.48 Million
58,965 Added 21.84%
328,981 $12.8 Million
Q1 2018

May 07, 2018
BUY
$18.43 - $28.8 $499,121 - $779,961
27,082 Added 11.15%
270,016 $7.45 Million
Q4 2017

Jan 17, 2018
BUY
$14.8 - $18.85 $1.21 Million - $1.54 Million
81,735 Added 50.7%
242,934 $4.4 Million
Q3 2017

Nov 13, 2017
BUY
$14.65 - $16.85 $2.36 Million - $2.72 Million
161,199
161,199 $2.6 Million

Others Institutions Holding HRTX

# of Institutions
185
Shares Held
130M
Call Options Held
1.56M
Put Options Held
27.1K
View Full List

About HERON THERAPEUTICS, INC.

HRTX Quotes by TradingView
  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $141M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email